Conversation March 9, 2021
Deborah Fuller, Albert H. Titus, Nevan Krogan

A number of technologies and tools got a chance to prove themselves for the first time in the context of COVID-19. Three researchers working in gene-based vaccines, wearable diagnostics and drug discovery explain how their work rose to the challenge of the pandemic, and their hopes that each technology is now poised to continue making big changes in medicine.

Genetic vaccines

Deborah Fuller, Professor of Microbiology, University of Washington

Thirty years ago, researchers for the first time injected mice with genes from a foreign pathogen to produce an immune response. Like many new discoveries, these first gene-based vaccines had their ups and downs. Early mRNA vaccines were hard to store and didn’t produce the right type of immunity. DNA vaccines...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Technology, Wearables
Bird Flu H5N1—What We Know So Far About Its Spread To Cows
Should You Worry About The Bird Flu? Here Are The Concerns
Covid-19 Pandemic Led To Growing Acceptance Of Doctors Withholding Treatment
ONC @ 20: A Tale of Optimism and Humility
Europe Strengthens Future Disease Defense

Share This Article